CELC
Celcuity LLC
NASDAQ: CELC · HEALTHCARE · BIOTECHNOLOGY
$121.35
+1.97% today
Updated 2026-04-30
Market cap
$5.80B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.79
Dividend yield
—
52W range
$10 – $129
Volume
0.7M
Celcuity LLC (CELC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.98M | $-2.89M | $-4.95M | $-6.08M | $-6.00M | $-7.15M | $-20.31M | $-36.01M | $-53.81M | $-83.47M | $-153.28M |
| Capital expenditures | $78982.00 | $40903.00 | $239848.00 | $629608.00 | $380201.00 | $89371.00 | $81898.00 | $158768.00 | $97644.00 | $249878.00 | $249000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $56507.00 | $187306.00 | $874386.00 | $1.17M | $1.04M | $1.76M | $2.61M | $4.64M | $4.90M | $6.99M | $21.38M |
| Free cash flow | $-2.06M | $-2.93M | $-5.19M | $-6.71M | $-6.38M | $-7.24M | $-20.39M | $-36.17M | $-53.91M | $-83.72M | $-153.53M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-3.22M | $13.25M | $2.79M | $-7.10M | $72.65M | $-59.71M | — | — | — |